×

What are you searching for?




Healthcare

4 Min read

GC PHARMAS HUNTERASE TO TREAT HUNTER SYNDROME FINDS NEW ALLY IN CHINA

Published On 09 Sep 2020 08:17 AM


SHARE THIS ARTICLE  


  • GC Pharma’s discovery, Hunterase for treatment of Hunter syndrome has been approved by the Chinese drug authority, the company said Wednesday.
  • Hunterase is suggested for long-term treatment of Hunter syndrome, and is the first of its kind to be officially approved for use by China’s National Medical Products Administration.


CAN Bridge Pharmaceuticals is the agency that has been given the....


Tags : Hunterase, hunter syndrome, GC Pharma, CAN Bridge Pharmaceuticals, Injectable IDS Enzyme,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)